BACKGROUND: Assessing health status in survivors of childhood cancer is increasingly important due to improved survival rates. However, there are limited estimates available for this population based on large samples and compared to population controls. METHODS: In a retrospective cohort study, 2,152 long-term survivors and 2,432 controls, aged 5-37, who had survived cancer during childhood or adolescence were compared on the Health Utilities Index Mark III (HUI3). Descriptive and logistic regression analyses were used to assess the effect of age at diagnosis, type of cancer and therapy received on HUI3 domains. MAJOR FINDINGS: More survivors than controls showed deficits in dexterity, ambulation, hearing, speech and cognition but not in vision, emotion or pain. The largest numbers of survivors reporting excess impairment was found in the cognition attribute. Survivors of central nervous system tumors were most likely to show impairments across multiple domains. Lastly, impairments in cognition were found most commonly in survivors exposed to cranio-spinal radiation at young ages. CONCLUSIONS: Seventy-five percent of childhood cancer survivors and 80% of controls were found to have two or fewer impaired attributes. Those reporting impairments that were most likely to be of clinical relevance were among survivors diagnosed with central nervous system and bone tumours, and those exposed to cranial radiation as young children. Tools assessing health status should be included in prospective trials to more clearly assess the contribution of therapy to reduced long-term health status.
BACKGROUND: Assessing health status in survivors of childhood cancer is increasingly important due to improved survival rates. However, there are limited estimates available for this population based on large samples and compared to population controls. METHODS: In a retrospective cohort study, 2,152 long-term survivors and 2,432 controls, aged 5-37, who had survived cancer during childhood or adolescence were compared on the Health Utilities Index Mark III (HUI3). Descriptive and logistic regression analyses were used to assess the effect of age at diagnosis, type of cancer and therapy received on HUI3 domains. MAJOR FINDINGS: More survivors than controls showed deficits in dexterity, ambulation, hearing, speech and cognition but not in vision, emotion or pain. The largest numbers of survivors reporting excess impairment was found in the cognition attribute. Survivors of central nervous system tumors were most likely to show impairments across multiple domains. Lastly, impairments in cognition were found most commonly in survivors exposed to cranio-spinal radiation at young ages. CONCLUSIONS: Seventy-five percent of childhood cancer survivors and 80% of controls were found to have two or fewer impaired attributes. Those reporting impairments that were most likely to be of clinical relevance were among survivors diagnosed with central nervous system and bone tumours, and those exposed to cranial radiation as young children. Tools assessing health status should be included in prospective trials to more clearly assess the contribution of therapy to reduced long-term health status.
Authors: Amanda K Shaw; Howard I Morrison; Kathy N Speechley; Elizabeth Maunsell; Maru Barrera; Dena Schanzer; Lisa Pogany; Marie Desmeules Journal: Chronic Dis Can Date: 2004 Summer-Fall
Authors: G H Verrips; M C Stuifbergen; A L den Ouden; G J Bonsel; R J Gemke; N Paneth; S P Verloove-Vanhorick Journal: J Clin Epidemiol Date: 2001-05 Impact factor: 6.437
Authors: J Kelaghan; M H Myers; J J Mulvihill; J Byrne; R R Connelly; D F Austin; L C Strong; J W Meigs; H B Latourette; G F Holmes Journal: Med Pediatr Oncol Date: 1988
Authors: Melissa M Hudson; Ann C Mertens; Yutaka Yasui; Wendy Hobbie; Hegang Chen; James G Gurney; Mark Yeazel; Christopher J Recklitis; Neyssa Marina; Leslie R Robison; Kevin C Oeffinger Journal: JAMA Date: 2003-09-24 Impact factor: 157.335
Authors: Ann C Mertens; Sarah Brand; Kirsten K Ness; Zhenghong Li; Pauline A Mitby; Anne Riley; Andrea Farkas Patenaude; Lonnie Zeltzer Journal: Psychooncology Date: 2013-10-04 Impact factor: 3.894
Authors: Lorna Finnegan; Joan L Shaver; Shannon N Zenk; Diana J Wilkie; Carol Estwing Ferrans Journal: Oncol Nurs Forum Date: 2010-11 Impact factor: 2.172
Authors: William Furlong; Charlene Rae; David Feeny; Richard D Gelber; Caroline Laverdiere; Bruno Michon; Lewis Silverman; Stephen Sallan; Ronald Barr Journal: Pediatr Blood Cancer Date: 2012-01-31 Impact factor: 3.167
Authors: Anne C Kirchhoff; Wendy Leisenring; Kevin R Krull; Kirsten K Ness; Debra L Friedman; Gregory T Armstrong; Marilyn Stovall; Elyse R Park; Kevin C Oeffinger; Melissa M Hudson; Leslie L Robison; Thomas Wickizer Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: Jean-Eric Tarride; Natasha Burke; Matthias Bischof; Robert B Hopkins; Linda Goeree; Kaitryn Campbell; Feng Xie; Daria O'Reilly; Ron Goeree Journal: Health Qual Life Outcomes Date: 2010-01-27 Impact factor: 3.186
Authors: Fiona S M Schulte; Michaela Patton; Nicole M Alberts; Alicia Kunin-Batson; Barbara A Olson-Bullis; Caitlin Forbes; K Brooke Russell; Alexandra Neville; Lauren C Heathcote; Cynthia W Karlson; Nicole M Racine; Courtney Charnock; Matthew C Hocking; Pia Banerjee; Perri R Tutelman; Melanie Noel; Kevin R Krull Journal: Cancer Date: 2020-10-28 Impact factor: 6.860